Figure 1.
Survival curve of the start of carboplatin desensitization; median overall survival was 42.2 ± 8.6 mo (25.3–59.1 mo). The 1-, 2-, and 5-yr survival rates were 92.6%, 75.6%, and 47.2%, respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.